These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 19718467)

  • 21. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
    Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM
    Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three cases of congenital dysfibrinogenemia in unrelated Chinese families: heterozygous missense mutation in fibrinogen alpha chain Argl6His.
    Luo M; Deng D; Xiang L; Cheng P; Liao L; Deng X; Yan J; Lin F
    Medicine (Baltimore); 2016 Sep; 95(39):e4864. PubMed ID: 27684817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinogen Guarenas, an abnormal fibrinogen with an Aalpha-chain truncation due to a nonsense mutation at Aalpha 467 Glu (GAA)-->stop (TAA).
    Marchi R; Carvajal Z; Meyer M; Soria J; Ruiz-Saez A; Arocha-Piñango CL; Weisel JW
    Thromb Res; 2006; 118(5):637-50. PubMed ID: 16406498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterozygous abnormal fibrinogen Osaka III with the replacement of gamma arginine-275 by histidine has an apparently higher molecular weight gamma-chain variant.
    Yoshida N; Imaoka S; Hirata H; Matsuda M; Asakura S
    Thromb Haemost; 1992 Nov; 68(5):534-8. PubMed ID: 1455400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen.
    Haverkate F; Samama M
    Thromb Haemost; 1995 Jan; 73(1):151-61. PubMed ID: 7740487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biophysical characterization of fibrinogen Caracas I with an Aalpha-chain truncation at Aalpha-466 Ser: identification of the mutation and biophysical characterization of properties of clots from plasma and purified fibrinogen.
    Marchi R; Meyer M; de Bosch N; Soria J; Arocha-Piñango CL; Weisel JW
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):285-93. PubMed ID: 15166913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinogen Seoul (FGG Ala341Asp): a novel mutation associated with hypodysfibrinogenemia.
    Song KS; Park NJ; Choi JR; Doh HJ; Chung KH
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):338-43. PubMed ID: 16959688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of dysfibrinogenemia without hemorrhagic diathesis or thromboembolism linked to a new mutation p.H103N in fibrinogen γ chain].
    Devignes J; Hanss M; Chabaud A; Toussaint-Hacquard M; Mansuy L; De Mazancourt P; Lecompte T
    Ann Biol Clin (Paris); 2013; 71(4):489-95. PubMed ID: 23906582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrinogen Matsumoto III: a variant with gamma275 Arg-->Cys (CGC-->TGC)--comparison of fibrin polymerization properties with those of Matsumoto I (gamma364 Asp-->His) and Matsumoto II (gamma308 Asn-->Lys).
    Terasawa F; Okumura N; Higuchi Y; Ishikawa S; Tozuka M; Ishida F; Kitano K; Katsuyama T
    Thromb Haemost; 1999 May; 81(5):763-6. PubMed ID: 10365751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysfibrinogenemia in childhood: two cases of congenital dysfibrinogens.
    Kotlín R; Blažek B; Suttnar J; Malý M; Kvasnička J; Dyr JE
    Blood Coagul Fibrinolysis; 2010 Oct; 21(7):640-8. PubMed ID: 20829681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrinogen Alès: a homozygous case of dysfibrinogenemia (gamma-Asp(330)-->Val) characterized by a defective fibrin polymerization site "a".
    Lounes KC; Soria C; Mirshahi SS; Desvignes P; Mirshahi M; Bertrand O; Bonnet P; Koopman J; Soria J
    Blood; 2000 Nov; 96(10):3473-9. PubMed ID: 11071644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel mutation (deletion of Aalpha-Asn 80) in an abnormal fibrinogen: fibrinogen Caracas VI. Consequences of disruption of the coiled coil for the polymerization of fibrin: peculiar clot structure and diminished stiffness of the clot.
    Marchi RC; Meyer MH; de Bosch NB; Arocha-Piñango CL; Weisel JW
    Blood Coagul Fibrinolysis; 2004 Oct; 15(7):559-67. PubMed ID: 15389122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A frameshift mutation in the human fibrinogen Aalpha-chain gene (Aalpha(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo.
    Margaglione M; Vecchione G; Santacroce R; D'Angelo F; Casetta B; Papa ML; Grandone E; Di Minno G
    Thromb Haemost; 2001 Dec; 86(6):1483-8. PubMed ID: 11776317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
    Yan J; Luo M; Cheng P; Liao L; Deng X; Deng D; Lin F
    Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function.
    Undas A; Zdziarska J; Iwaniec T; Stepien E; Skotnicki AB; de Moerloose P; Neerman-Arbez M
    Thromb Haemost; 2009 May; 101(5):975-6. PubMed ID: 19404553
    [No Abstract]   [Full Text] [Related]  

  • 36. Two novel fibrinogen variants in the C-terminus of the Bβ-chain: fibrinogen Rokycany and fibrinogen Znojmo.
    Kotlín R; Reicheltová Z; Suttnar J; Salaj P; Hrachovinová I; Riedel T; Malý M; Oravec M; Kvasnicka J; Dyr JE
    J Thromb Thrombolysis; 2010 Oct; 30(3):311-8. PubMed ID: 20640913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel fibrinogen variant--Praha I: hypofibrinogenemia associated with gamma Gly351Ser substitution.
    Kotlín R; Chytilová M; Suttnar J; Salaj P; Riedel T; Santrůcek J; Klener P; Dyr JE
    Eur J Haematol; 2007 May; 78(5):410-6. PubMed ID: 17331136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homophenotypic Aalpha R16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B release.
    Galanakis DK; Neerman-Arbez M; Scheiner T; Henschen A; Hubbs D; Nagaswami C; Weisel JW
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):731-7. PubMed ID: 17982313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinogen Caracas I: a dysfibrinogenemia with a hemorrhagic diathesis associated with diminished fibrin fiber diameter and reduced fibrin gel porosity.
    Marchi R; Lundberg U; de Bosch NB; Arocha-Piñango CL
    Blood Coagul Fibrinolysis; 1998 Nov; 9(8):733-9. PubMed ID: 9890716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An engineered fibrinogen variant AαQ328,366P does not polymerise normally, but retains the ability to form α cross-links.
    Park R; Ping L; Song J; Seo JY; Choi TY; Choi JR; Gorkun OV; Lord ST
    Thromb Haemost; 2013 Feb; 109(2):199-206. PubMed ID: 23224113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.